Cardio-Oncology and Breast Cancer Therapies

被引:0
作者
Singh, Rohit [1 ,2 ]
Patel, Krina [3 ]
Xu, Haze [1 ,2 ]
Adeniyi, Aderonke [4 ]
Upshaw, Jenica N. [3 ]
Van Buren, Peter [5 ]
Kaufman, Peter A. [1 ,2 ]
Dittus, Kim [6 ]
Landry, Kara K. [1 ,2 ]
机构
[1] Univ Vermont, Larner Coll Med, Dept Med, Div Hematol Oncol, Burlington, VT 05405 USA
[2] Univ Vermont, Canc Ctr, Burlington, VT 05405 USA
[3] Tufts Med Ctr, Dept Med, Div Cardiol, Boston, MA USA
[4] Wake Forest Baptist Med Ctr, Dept Internal Med, Div Cardiol, Winston Salem, NC USA
[5] Univ Vermont, Larner Coll Med, Dept Med, Div Cardiol, Burlington, VT USA
[6] Univ Wisconsin, Dept Med, Div Hematol Oncol, Madison, WI USA
关键词
Breast cancer; Cardio-oncology; Cardiotoxicity; IMMUNE CHECKPOINT INHIBITORS; PLUS ENDOCRINE THERAPY; ANTHRACYCLINE CARDIOTOXICITY; FOLLOW-UP; ADJUVANT CHEMOTHERAPY; TRASTUZUMAB EMTANSINE; OPEN-LABEL; PREDICTIVE MODEL; HEART-FAILURE; DOXORUBICIN;
D O I
10.1007/s11864-025-01311-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Assessing cardiac risk prior to initiating breast cancer treatment, monitoring cardiac function during treatment, and implementing appropriate follow-up strategies are essential components of managing cardiotoxicity in breast cancer patients. A comprehensive cardiovascular evaluation should be conducted before treatment, including a detailed medical history, physical examination, and baseline cardiac imaging. Risk stratification tools can aid in determining the individual patient's risk profile. Close monitoring of cardiac function, including regular assessment of left ventricular ejection fraction (LVEF) and monitoring for signs and symptoms of cardiac dysfunction, is crucial during treatment. Prompt action should be taken if an adverse cardiovascular event is detected, including considering discontinuing or modifying the treatment regimen. Appropriate follow-up care is essential to monitor for long-term cardiac effects and optimize cardiovascular health in breast cancer survivors. Regular cardiovascular assessments, lifestyle modifications, and collaboration between healthcare professionals are important in managing cardiotoxicity effectively.
引用
收藏
页码:385 / 397
页数:13
相关论文
共 50 条
[41]   Bradyarrhythmias in Cardio-Oncology [J].
Fonseca, Marta ;
Cheng, Evaline ;
Do, Duc ;
Haldar, Shouvik ;
Kutty, Shelby ;
Yang, Eric H. ;
Ghosh, Arjun K. ;
Guha, Avirup .
SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (03) :195-210
[42]   Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity The Role of Palliative Care [J].
Cheng, Richard K. ;
Kirkpatrick, James N. ;
Sorror, Mohamed L. ;
Barac, Ana .
JACC: CARDIOONCOLOGY, 2019, 1 (02) :314-317
[43]   How to Develop a Cardio-Oncology Clinic [J].
Snipelisky, David ;
Park, Jae Yoon ;
Lerman, Amir ;
Mulvagh, Sharon ;
Lin, Grace ;
Pereira, Naveen ;
Rodriguez-Porcel, Martin ;
Villarraga, Hector R. ;
Herrmann, Joerg .
HEART FAILURE CLINICS, 2017, 13 (02) :347-+
[44]   Cardio-Oncology Challenges in Elderly Patients [J].
Topa, Ester ;
De Rosa, Eliana ;
Cuomo, Alessandra ;
Curcio, Francesco ;
Rizza, Marika ;
Elia, Francesco ;
Flocco, Veronica ;
Attanasio, Umberto ;
Iengo, Martina ;
Fiore, Francesco ;
Luise, Maria Cristina ;
Arpino, Grazia ;
Bianco, Roberto ;
Carlomagno, Chiara ;
Giuliano, Mario ;
Formisano, Luigi ;
Picardi, Marco ;
Della Corte, Carminia Maria ;
Morgillo, Floriana ;
Martini, Giulia ;
Martinelli, Erika ;
Napolitano, Stefania ;
Troiani, Teresa ;
Esposito, Giovanni ;
Cittadini, Antonio ;
Iaccarino, Guido ;
Rengo, Giuseppe ;
Abete, Pasquale ;
Mercurio, Valentina ;
Tocchetti, Carlo Gabriele .
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (09)
[45]   Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism [J].
Zhao, Yiqi ;
Jia, Hao ;
Hua, Xiumeng ;
An, Tao ;
Song, Jiangping .
CURRENT CARDIOLOGY REPORTS, 2023, 25 (08) :863-878
[46]   Cardio-Oncology Rehabilitation-Present and Future Perspectives [J].
Elad, Boaz ;
Habib, Manhal ;
Caspi, Oren .
LIFE-BASEL, 2022, 12 (07)
[47]   A new classification of cardio-oncology syndromes [J].
Rudolf A. de Boer ;
Joseph Pierre Aboumsallem ;
Valentina Bracun ;
Douglas Leedy ;
Richard Cheng ;
Sahishnu Patel ;
David Rayan ;
Svetlana Zaharova ;
Jennifer Rymer ;
Jennifer M. Kwan ;
Joshua Levenson ;
Claudio Ronco ;
Paaladinesh Thavendiranathan ;
Sherry-Ann Brown .
Cardio-Oncology, 7
[48]   A new classification of cardio-oncology syndromes [J].
de Boer, Rudolf A. ;
Aboumsallem, Joseph Pierre ;
Bracun, Valentina ;
Leedy, Douglas ;
Cheng, Richard ;
Patel, Sahishnu ;
Rayan, David ;
Zaharova, Svetlana ;
Rymer, Jennifer ;
Kwan, Jennifer M. ;
Levenson, Joshua ;
Ronco, Claudio ;
Thavendiranathan, Paaladinesh ;
Brown, Sherry-Ann .
CARDIO-ONCOLOGY, 2021, 7 (01)
[49]   Clinical Practice Guidelines in Cardio-Oncology [J].
Leong, Darryl P. ;
Lenihan, Daniel J. .
HEART FAILURE CLINICS, 2022, 18 (03) :489-501
[50]   The role and mechanism of TXNDC5 in cardio-oncology: Killing two birds with one stone? [J].
An, Na ;
Zhang, Xiaoyu ;
Lin, Hongyuan ;
Xu, Qianqian ;
Dai, Qianqian ;
Kong, Yifan ;
Han, Songjie ;
Li, Xiao ;
Yang, Xinyu ;
Xing, Yanwei ;
Shang, Hongcai .
CURRENT PROBLEMS IN CARDIOLOGY, 2025, 50 (03) :102951